AUGX | Augmedix, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.3400 - 2.3500
52 Week Range	0.7300 - 6.25
Beta	-0.33
Implied Volatility	48.03%
IV Rank	100.00%
Day's Volume	23,983
Average Volume	834,649
Shares Outstanding	49,428,100
Market Cap	116,156,035
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2021-03-31

Valuation
Profitability
Growth
Health
P/E Ratio	-5.00
Forward P/E Ratio	N/A
EPS	-0.47
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,430
Country	USA
Website	AUGX

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

AUGX's peers: SOPH, ZCMD, ACON, BEATW, EUDA, FOXO, MGRX, BFRG

*Chart delayed

Analyzing fundamentals for AUGX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see AUGX Fundamentals page.

Watching at AUGX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AUGX Technicals page.